Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
The MTA Cooperative Group trial (N=579) confirmed that medication management with stimulants, including mixed amphetamine salts, outperformed behavioral therapy alone and community care for core ADHD symptoms over 14 months 2
The new case will be heard by the same judge overseeing another MDL about GLP-1s, Karen Marston
Orforglipron is new to the market for GLP-1 weight loss
In a statement to Insider, Novo Nordisk, the company that makes Wegovy and Ozempic, said that Gila monsters and the discovery of exendin-4 "did not have anything to do with our decision to develop long-acting GLP-1 receptor agonists" for obesity, because "that was based on GLP-1 biology in humans." But the company also said that "the GLP-1-like effect of exendin-4" in Gila monsters was "an important contribution to the field," as it led to the development of the very first injectable drug of its kind
US$ 20.25
US$ 27.02
